These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

433 related items for PubMed ID: 17540193

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. [Nesiritide in heart failure: commercial success or therapeutic advance?].
    Stampfli T, Perrier A.
    Rev Med Suisse; 2006 Jan 25; 2(50):295-8. PubMed ID: 16503047
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Critical review and recommendations for nesiritide use in the emergency department.
    Collins SP, Hinckley WR, Storrow AB.
    J Emerg Med; 2005 Oct 25; 29(3):317-29. PubMed ID: 16183453
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Safety and tolerability of serial home infusions of nesiritide for advanced heart failure.
    Chung ES, Menon SG, Daly KA, Atkinson J, Peterson T, Robertson R, Ibanez K, Kereiakes DJ.
    Am J Cardiol; 2006 May 01; 97(9):1370-3. PubMed ID: 16635613
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Nesiritide as bridge to multi-organ transplantation: a case report.
    Cochrane AB, Fedson SE, Cronin DC.
    Transplant Proc; 2007 May 01; 39(1):308-10. PubMed ID: 17275531
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Rationale and design of the enoximone clinical trials program.
    Lowes BD, Shakar SF, Metra M, Feldman AM, Eichhorn E, Freytag JW, Gerber MJ, Liard JF, Hartman C, Gorczynski R, Evans G, Linseman JV, Stewart J, Robertson AD, Roecker EB, Demets DL, Bristow MR.
    J Card Fail; 2005 Dec 01; 11(9):659-69. PubMed ID: 16360960
    [Abstract] [Full Text] [Related]

  • 34. Nesiritide for the treatment of decompensated heart failure.
    Wylie JV, Tsao L.
    Expert Rev Cardiovasc Ther; 2004 Nov 01; 2(6):803-13. PubMed ID: 15500426
    [Abstract] [Full Text] [Related]

  • 35. Intermittent outpatient nesiritide infusion reduces hospital admissions in patients with advanced heart failure.
    Schwarz ER, Najam S, Akel R, Sulimanjee N, Bionat S, Rosanio S.
    J Cardiovasc Pharmacol Ther; 2007 Sep 01; 12(3):232-6. PubMed ID: 17875951
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Optimizing outcomes in the patient with acute decompensated heart failure.
    Mehra MR.
    Am Heart J; 2006 Mar 01; 151(3):571-9. PubMed ID: 16504617
    [Abstract] [Full Text] [Related]

  • 38. Nesiritide: a unique therapeutic cardiac peptide.
    Rayburn BK, Bourge RC.
    Rev Cardiovasc Med; 2001 Mar 01; 2 Suppl 2():S25-31. PubMed ID: 12439359
    [Abstract] [Full Text] [Related]

  • 39. Intermittent dobutamine treatment in patients with chronic refractory congestive heart failure: a randomized, double-blind, placebo-controlled study.
    Elis A, Bental T, Kimchi O, Ravid M, Lishner M.
    Clin Pharmacol Ther; 1998 Jun 01; 63(6):682-5. PubMed ID: 9663183
    [Abstract] [Full Text] [Related]

  • 40. Nesiritide: practical guide to its safe and effective use.
    Fonarow GC.
    Rev Cardiovasc Med; 2001 Jun 01; 2 Suppl 2():S32-5. PubMed ID: 12439360
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.